Sviss -
ítalska -
Swissmedic (Swiss Agency for Therapeutic Products)
sufenta forte soluzione iniettabile
piramal critical care limited, london, zweigniederlassung rüschlikon - sufentanilum - soluzione iniettabile - sufentanilum 50 µg ut sufentanili citras, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile, ad solutionem pro 1 ml corresp., natrium 3.54 mg. - un narcotico analgesico - synthetika
Sviss -
ítalska -
Swissmedic (Swiss Agency for Therapeutic Products)
physiotens forte 0,4 mg compresse rivestite con film
viatris pharma gmbh - moxonidinum - compresse rivestite con film - moxonidinum 0.4 mg, lactosum monohydricum 95.60 mg, povidonum k 25, crospovidonum, magnesii stearas, Überzug: hypromellosum, ethylcellulosum, macrogolum 6000, talcum, e 171, e 172 (rubrum), pro compresso obducto. - antihypertonicum - synthetika
Sviss -
ítalska -
Swissmedic (Swiss Agency for Therapeutic Products)
atrovent per inalazione inqua ®
boehringer ingelheim (schweiz) gmbh - ipratropii bromidum - per inalazione inqua ® - ipratropii bromidum 0.25 mg, antiox.: dinatrii edetas, conserv.: benzalkonii chloridum, excipiens ad una soluzione per 1 ml. - bronchospasmolytikum - sintetica umana
Evrópusambandið -
ítalska -
EMA (European Medicines Agency)
imprida
novartis europharm ltd - valsartan, amlodipine (as amlodipine besilate) - ipertensione - agenti che agiscono sul sistema renina-angiotensina - trattamento dell'ipertensione essenziale. imprida è indicato in pazienti la cui pressione arteriosa non è adeguatamente controllata con amlodipina o valsartan in monoterapia.
Sviss -
ítalska -
Swissmedic (Swiss Agency for Therapeutic Products)
farmorubicin solution 10 mg/5 ml lösung zur intravesikalen anwendung/injektionslösung
pfizer ag - epirubicini hydrochloridum - lösung zur intravesikalen anwendung/injektionslösung - epirubicini hydrochloridum 10 mg, natrii chloridum corresp. natrium 17.7 mg, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 5 ml. - farmaco - synthetika
Sviss -
ítalska -
Swissmedic (Swiss Agency for Therapeutic Products)
farmorubicin solution 50 mg/25 ml lösung zur intravesikalen anwendung/injektionslösung
pfizer ag - epirubicini hydrochloridum - lösung zur intravesikalen anwendung/injektionslösung - epirubicini hydrochloridum 50 mg, natrii chloridum corresp. natrium 88.51 mg, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 25 ml. - farmaco - synthetika
Sviss -
ítalska -
Swissmedic (Swiss Agency for Therapeutic Products)
farmorubicin solution 200 mg/100 ml lösung zur intravesikalen anwendung/injektionslösung
pfizer ag - epirubicini hydrochloridum - lösung zur intravesikalen anwendung/injektionslösung - epirubicini hydrochloridum 200 mg, natrii chloridum, natrium 354.05 mg, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 100 ml. - farmaco - synthetika
Evrópusambandið -
ítalska -
EMA (European Medicines Agency)
fampridine accord
accord healthcare s.l.u. - fampridine - sclerosi multipla - altri farmaci sul sistema nervoso - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).
Sviss -
ítalska -
Swissmedic (Swiss Agency for Therapeutic Products)
betoptic-s single dose augentropfensuspension
medius ag - betaxololum - augentropfensuspension - betaxololum 2.5 mg ut betaxololi hydrochloridum, natrii polystyrensulfonas, carbomerum 974p, mannitolum, acidum hydrochloridum aut natrii hydroxidum, aqua, ad suspensionem pro 1 ml. - il glaucoma - synthetika